Novel surface antigen

Abstract

The invention provides a novel surface polypeptide from Neisseria meningitidis as well as nucleic acid and nucleic acid sequence homologues encoding this protein. Pharmaceutical compositions containing the polypeptide and nucleic acids of the invention are also disclosed as well as methods useful in the treatment, prevention and diagnosis of N. meningitidis infection.

1 - 34 . (canceled) 
     
     
         35 . An isolated polypeptide comprising a member selected from the group consisting of (a) the amino acid sequence according to SEQ ID NO:2 and (b) an immunogenic fragment of at least 15 contiguous amino acids according to SEQ ID NO:2; wherein the immunogenic fragment, when administered to a subject in a suitable composition which can include an adjuvant, or a suitable carrier coupled to the polypeptide, induces an antibody or T-cell mediated immune response that recognizes the isolated polypeptide according to SEQ ID NO:2. 
     
     
         36 . An isolated polypeptide comprising a member selected from the group consisting of (a) the amino acid sequence according to SEQ ID NO:2 and (b) an immunogenic fragment of at least 10 contiguous amino acids according to SEQ ID NO:2; wherein the immunogenic fragment, when administered to a subject in a suitable composition which can include an adjuvant, or a suitable carrier coupled to the polypeptide, induces an antibody or T-cell mediated immune response that recognizes the isolated polypeptide according to SEQ ID NO:2. 
     
     
         37 . An isolated polypeptide comprising a member selected from the group consisting of (a) the amino acid sequence according to SEQ ID NO:2 and (b) an immunogenic fragment of at least 20 contiguous amino acids according to SEQ ID NO:2; wherein the immunogenic fragment, when administered to a subject in a suitable composition which can include an adjuvant, or a suitable carrier coupled to the polypeptide, induces an antibody or T-cell mediated immune response that recognizes the isolated polypeptide of according to SEQ ID NO:2. 
     
     
         38 . The isolated polypeptide of  claim 35 , wherein the polypeptide is a fragment and induces an antibody response when administered to the subject. 
     
     
         39 . The isolated polypeptide of  claim 36 , wherein the polypeptide is a fragment and induces an antibody response when administered to the subject. 
     
     
         40 . The isolated polypeptide of  claim 37 , wherein the polypeptide is a fragment and induces an antibody response when administered to the subject. 
     
     
         41 . An isolated polypeptide comprising a member selected from the group consisting of (a) the amino acid sequence according to SEQ ID NO:2 and (b) an immunogenic fragment of at least 15 contiguous amino acids of SEQ ID NO:2; wherein the immunogenic fragment, when administered to a subject can elicit an immune response against the isolated polypeptide according to SEQ ID NO:2. 
     
     
         42 . An isolated polypeptide comprising a member selected from the group consisting of (a) the amino acid sequence SEQ ID NO:2 and (b) an immunogenic fragment of at least 10 contiguous amino acids of SEQ ID NO:2; wherein the immunogenic fragment, when administered to a subject can elicit an immune response against the isolated polypeptide according to SEQ ID NO:2. 
     
     
         43 . An isolated polypeptide comprising a member selected from the group consisting of (a) the amino acid sequence SEQ ID NO:2 and (b) an immunogenic fragment of at least 20 contiguous amino acids of SEQ ID NO:2; wherein the immunogenic fragment, when administered to a subject can elicit an immune response against the isolated polypeptide according to SEQ ID NO:2. 
     
     
         44 . The isolated polypeptide of  claim 35 , wherein the polypeptide is (a) the amino acid sequence according to SEQ ID NO:2. 
     
     
         45 . The isolated polypeptide of  claim 36 , wherein the polypeptide is (a) the amino acid sequence according to SEQ ID NO:2. 
     
     
         46 . The isolated polypeptide of  claim 37 , wherein the polypeptide is (a) the amino acid sequence according to SEQ ID NO:2. 
     
     
         47 . The isolated polypeptide of  claim 41 , wherein the polypeptide is (a) the amino acid sequence according to SEQ ID NO:2. 
     
     
         48 . The isolated polypeptide of  claim 42 , wherein the polypeptide is (a) the amino acid sequence according to SEQ ID NO:2. 
     
     
         49 . The isolated polypeptide of  claim 43 , wherein the polypeptide is (a) the amino acid sequence according to SEQ ID NO:2.